Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors
about
Overutilization of proton-pump inhibitors: what the clinician needs to knowChronic proton pump inihibitor therapy and calcium metabolism25 Years of Proton Pump Inhibitors: A Comprehensive Review.Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies.Perils and pitfalls of long-term effects of proton pump inhibitors.Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT projectUse of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implicationsProton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.Risk of fracture and pneumonia from acid suppressive drugs.Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesiumFactors associated with the initiation of proton pump inhibitors in corticosteroid users.Adverse effects of long-term proton pump inhibitor therapy.Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.Hip fracture risk in patients with a diagnosis of pernicious anemia.Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health InitiativeUse of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control studyThe safety of drugs used in acid-related disorders and functional gastrointestinal disorders.Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort studyInhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trialEffects of long-term administration of omeprazole on bone mineral density and the mechanical properties of the bone.Acid-suppressive medications and risk of fracture: an updated meta-analysis.A Proton Pump Inhibitor's Effect on Bone Metabolism Mediated by Osteoclast Action in Old Age: A Prospective Randomized StudyUse of proton pump inhibitors is associated with fractures in young adults: a population-based study.Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors.Canadian Association of Gastroenterology position statement: hip fracture and proton pump inhibitor therapy-a 2013 update.Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting.Esomeprazole: a proton pump inhibitor.The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study.Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.The relationship among proton pump inhibitors, bone disease and fracture.Thiazolidinediones and fracture risk in patients with Type 2 diabetes.Long-term acid inhibition: benefits and harms.The risks of PPI therapy.Fracture risk and bone mineral density reduction associated with proton pump inhibitors.Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?Gastric acid, calcium absorption, and their impact on bone health.
P2860
Q24634086-2FAB81E1-1FF4-44CB-859D-98525D32C5BAQ27016636-7A8C8EEA-0A19-4D18-9470-34E578B4C15FQ28070003-ADDD7728-0D73-4D77-A67D-53DA83E4F013Q28072141-806B433C-5284-41EC-8783-0B1986680772Q30928614-8DA9E421-503B-4974-A066-B80FC56CB4A2Q33409626-235E8C6C-D4B0-4A45-8113-ED8EE6269332Q33851671-1DCFB7F3-6DC1-40E4-9C95-A073B734A1D6Q33893627-C26415B9-5D40-4901-A589-A825ED9469D3Q33949498-4F957C67-3057-4D6F-8268-CCEE35B7017CQ33987564-870A8D44-8D62-4D0A-A0C5-011C54BB7A17Q34092977-134BDF9E-20E9-46B4-9916-44EB4B232042Q34140914-CF23F65F-67B8-46AA-98D3-A08F16E42DABQ34141425-6FD7E0A5-198C-4A6C-858B-A01655BDA941Q34167899-ACF8D126-289B-464A-8276-742C58F6905CQ34186827-7B20D7AC-C3B5-47D5-B29A-0C2F3AC7B4F4Q34196326-C579016E-7EB8-4158-8BB6-639FE0CAB33FQ34554705-DB28A745-1AC4-4AF9-8720-2930E84DC149Q34557174-F09C81E9-929C-489A-A534-C3E0926B19E4Q35052602-C810E2BB-9B6F-4410-9EE3-8D18C910132DQ35072261-9C1BE722-BD92-4D30-8296-24C28F3E72D9Q35173200-10CE6AAC-CEFF-4D9C-8ABB-0300FCB7A230Q35719101-22F5A42E-E6C1-478B-B755-CD6126586F13Q35853968-B7724688-54F6-4236-854C-6249FCD68F71Q35901581-54C8604E-644C-42DC-942F-B470D3EF6EE7Q35959430-B100D114-5E6D-491F-86D8-13D0F96B6BF1Q36037123-11DCF989-5199-4071-B508-E3625F1AE17FQ36075131-C87D79CA-8F81-450D-BAC1-58390214DB6DQ37108491-CAC91D92-861C-4C17-9A6A-1024E14AA6A1Q37247769-41BC2A8C-1211-4AB6-B104-EDDD84727F46Q37378002-9CBEB50E-F576-40DB-884C-7C3362F6A12CQ37390644-D6E75382-ADE9-442C-B711-A24294613AECQ37395858-ADDA2B97-0A18-4F76-911D-97CD43506B26Q37864076-3F4B8364-93FD-43A9-AF92-50CD6948CBA2Q37877712-B101342D-532A-42D1-9CE9-4959FF2C3869Q37889370-DB4266CA-A69C-4790-9E3D-86A849BB4D2FQ37957704-8D57F5C5-F5BE-471F-BFE5-0983F59992C9Q37983706-2374705E-2098-473E-B949-5A276F2E9C5CQ37990890-09129EB0-212A-413F-AC57-C065305B6D4CQ38011261-53FC7A81-286B-4B1B-9C0E-051F01D3EF0CQ38072903-751AC1B8-7A6C-4ABF-9837-9B81D249E1BA
P2860
Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Proton Pump Inhibitor Use and ...... nts without Major Risk Factors
@en
Proton Pump Inhibitor Use and ...... nts without Major Risk Factors
@nl
type
label
Proton Pump Inhibitor Use and ...... nts without Major Risk Factors
@en
Proton Pump Inhibitor Use and ...... nts without Major Risk Factors
@nl
prefLabel
Proton Pump Inhibitor Use and ...... nts without Major Risk Factors
@en
Proton Pump Inhibitor Use and ...... nts without Major Risk Factors
@nl
P2860
P356
P1433
P1476
Proton Pump Inhibitor Use and ...... nts without Major Risk Factors
@en
P2093
James A Kaye
P2860
P304
P356
10.1592/PHCO.28.8.951
P407
P50
P577
2008-08-01T00:00:00Z